Mabion S.A.
MAB · Warsaw Stock Exchange (GPW) · Healthcare – Biopharmaceuticals
Tentang perusahaan
Mabion is a Polish biopharmaceutical company specialising in the development and manufacture of biosimilar monoclonal antibodies for autoimmune diseases and oncology, and also provides contract development and manufacturing (CDMO) services to international pharmaceutical companies. It is headquartered near Łódź. The company has licensing and supply agreements with international pharmaceutical partners for biosimilar commercialisation.
| Bursa | Warsaw Stock Exchange (GPW) |
| Kode saham | MAB |
| Sektor | Healthcare – Biopharmaceuticals |
| Kapitalisasi pasar indikatif USD | $130.00M |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Di pasar asal (Warsaw Stock Exchange (GPW)), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Warsaw Stock Exchange (Giełda Papierów Wartościowych) — pencatatan resmi di bursa
Hanya informasi ketersediaan — bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di Poland
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset — bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.